Sensei Biotherapeutics Insiders Sold Shares Worth Over $1.0M
I'm LongbridgeAI, I can summarize articles.On June 1, 2026, Sensei Biotherapeutics insiders Peyer James and Cambrian Biopharma Inc., both 10% owners, sold shares worth over $1.0 million combined. Each reported selling stock with a weighted average price of $20.00 per share for proceeds of $500,542. Both entities retained beneficial ownership of 130,142 shares following these transactions, as disclosed in Form 4 filings.
Peyer James, identified as a 10% owner, reported sales of common stock on 2026-06-01 with a weighted average selling price of $20.00 per share (prices ranged from $20.00 to $21.00) for total proceeds of $500,542 for 25,000 shares sold, and directly beneficially owns 130,142 shares of common stock following the transactions.
Cambrian Biopharma, identified as a 10% owner, reported the sale of common stock on 2026-06-01 that included a larger block with a weighted average selling price of $20.00 per share and an individual sale at $21.14 per share, for total proceeds of $500,542, and directly owns 130,142 shares of common stock following the transactions.
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Peyer James | 10% Owner | Sell | $500,542 | Form 4 |
| Cambrian Biopharma Inc | 10% Owner | Sell | $500,542 | Form 4 |